Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: A phase II study of the EORTC Head and Neck Cancer Cooperative Group-Reference-Cited by-同舟云学术

Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: A phase II study of the EORTC Head and Neck Cancer Cooperative Group

Published:1993-11 Issue:9 Volume:4 Page:785-788
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Vermorken J.B.,Verweij J.,de Mulder P.H.M.,Cognetti F.,Clavel M.,Rodenhuis S.,Kirkpatrick A.,Snow G.B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/4/9/785/408246/4-9-785.pdf

Reference13 articles.

1. Chemotherapy for salivary gland cancer;Suen;Laryngoscope,1982

2. Chemotherapy for salivary gland cancer;Kaplan;Otolaryngol Head Neck Surg,1986

3. Chemotherapy for adenoid cystic carcinoma of the head and neck;Inuyama;Jibi Inkoka,1981

4. Phase II study with cisplatin (DDP) for advanced carcinoma of salivary gland origin;Licitra;Proc ASCO,1988

5. Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck;De Haan;Head & Neck,1992

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus method;European Annals of Otorhinolaryngology, Head and Neck Diseases;2023-12

2. Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus method;European Annals of Otorhinolaryngology, Head and Neck Diseases;2023-11

3. A molecular guide to systemic therapy in salivary gland carcinoma;Head & Neck;2023-03

4. Recent Advances, Systemic Therapy, and Molecular Targets in Adenoid Cystic Carcinoma of the Head and Neck;Journal of Clinical Medicine;2023-02-12

5. The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?;International Journal of Molecular Sciences;2022-11-28